482 related articles for article (PubMed ID: 35144840)
1. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.
Mottl AK; Alicic R; Argyropoulos C; Brosius FC; Mauer M; Molitch M; Nelson RG; Perreault L; Nicholas SB
Am J Kidney Dis; 2022 Apr; 79(4):457-479. PubMed ID: 35144840
[TBL] [Abstract][Full Text] [Related]
2. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD.
Mottl AK; Nicholas SB
Am J Kidney Dis; 2024 Mar; 83(3):277-287. PubMed ID: 38142396
[TBL] [Abstract][Full Text] [Related]
3. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
[TBL] [Abstract][Full Text] [Related]
4. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
[TBL] [Abstract][Full Text] [Related]
5. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD.
Drawz PE; Beddhu S; Bignall ONR; Cohen JB; Flynn JT; Ku E; Rahman M; Thomas G; Weir MR; Whelton PK
Am J Kidney Dis; 2022 Mar; 79(3):311-327. PubMed ID: 35063302
[TBL] [Abstract][Full Text] [Related]
6. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment.
de Boer IH; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Khunti K; Liew A; Michos ED; Navaneethan SD; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Zoungas S; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Rossing P
Kidney Int; 2020 Oct; 98(4):839-848. PubMed ID: 32653403
[TBL] [Abstract][Full Text] [Related]
7. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
Navaneethan SD; Zoungas S; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Liew A; Michos ED; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Craig JC; Tunnicliffe DJ; Tonelli M; Cheung M; Earley A; Rossing P; de Boer IH; Khunti K
Ann Intern Med; 2023 Mar; 176(3):381-387. PubMed ID: 36623286
[TBL] [Abstract][Full Text] [Related]
8. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
[TBL] [Abstract][Full Text] [Related]
9. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S
Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541
[TBL] [Abstract][Full Text] [Related]
10. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
de Boer IH; Khunti K; Sadusky T; Tuttle KR; Neumiller JJ; Rhee CM; Rosas SE; Rossing P; Bakris G
Kidney Int; 2022 Nov; 102(5):974-989. PubMed ID: 36202661
[TBL] [Abstract][Full Text] [Related]
11. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
[TBL] [Abstract][Full Text] [Related]
12. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
13. HbA1c and beyond.
Rossing P
Nephrol Dial Transplant; 2023 Jan; 38(1):34-40. PubMed ID: 34383945
[TBL] [Abstract][Full Text] [Related]
14. [New guideline on diabetes management in chronic kidney disease].
Wanner C; Busch M
Inn Med (Heidelb); 2023 Mar; 64(3):219-224. PubMed ID: 36745249
[TBL] [Abstract][Full Text] [Related]
15. Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.
Rossing P; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Khunti K; Liew A; Michos ED; Navaneethan SD; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Zoungas S; Craig JC; Tunnicliffe DJ; Tonelli MA; Cheung M; Earley A; de Boer IH
Kidney Int; 2022 Nov; 102(5):990-999. PubMed ID: 36272755
[TBL] [Abstract][Full Text] [Related]
16. Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape.
Mende CW
Adv Ther; 2022 Jan; 39(1):148-164. PubMed ID: 34846711
[TBL] [Abstract][Full Text] [Related]
17. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
[TBL] [Abstract][Full Text] [Related]
18. Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study.
Forbes AK; Hinton W; Feher MD; Elson W; Joy M; Ordóñez-Mena JM; Fan X; Cole NI; Banerjee D; Suckling RJ; de Lusignan S; Swift PA
EClinicalMedicine; 2024 Feb; 68():102426. PubMed ID: 38304744
[TBL] [Abstract][Full Text] [Related]
19. Cardiorenal disease management in type 2 diabetes: An expert consensus.
Mohan V; Singh AK; Zargar AH; Almeida A; Bhalla AK; Mohan JC; Dalal J; Sahay M; Mohanan PP; Maitra S; Ghosh S; Jeloka T; Kaul U; Sakhuja V; Das MK
Diabetes Metab Syndr; 2022 Dec; 16(12):102661. PubMed ID: 36375366
[TBL] [Abstract][Full Text] [Related]
20. Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease.
Nee R; Yuan CM; Narva AS; Yan G; Norris KC
Nephrol Dial Transplant; 2023 Feb; 38(3):532-541. PubMed ID: 36264305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
